ASTRO announces 10 top-rated studies to be featured in news briefings at annual meeting

By News Release

 

The American Society for Radiation Oncology (ASTRO) has announced that the 10 top-rated studies that will be highlighted in the press program for the 2018 ASTRO Annual Meeting. Researchers will present their findings in three news briefings held October 21 through 23 in room 225-D of the Henry B. Gonzalez Convention Center in San Antonio and via live webcast. 

The briefing schedule is as follows:

Advances in Breast and Lung Cancers
Sunday, October 21, 1:00 – 2:00 p.m. CT

  • “Randomized Trial Evaluating Radiation following Surgical Excision for ‘Good Risk’ DCIS: 12-Year Report from NRG/RTOG 9804,” presented by Dr. Beryl McCormick, Memorial Sloan Kettering Cancer Center (Abstract LBA-1)
  • “FAST Phase III RCT of Radiation Therapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015),” presented by Dr. Murray Brunt, Institute of Cancer Research, London (Abstract LBA-2)
  • “Local Consolidative Therapy (LCT) Improves Overall Survival (OS) Compared to Maintenance Therapy/Observation in Oligometastatic Non-Small Cell Lung Cancer (NSCLC): Final Results of a Multicenter, Randomized, Controlled Phase 2 Trial,” presented by Dr. Daniel Gomez, University of Texas MD Anderson Cancer Center (Abstract LBA-3)

Advances in Genitourinary Cancers
Monday, October 22, 11:00 a.m. – 12:00 p.m. CT

  • “Androgen Receptor Activity and Radiotherapeutic Sensitivity in African-American Men with Prostate Cancer: A Large-Scale Gene Expression Analysis and Meta-analysis of RTOG Trials,” presented by Dr. Daniel Spratt, University of Michigan (Abstract 4)
  • “Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study,” presented by Dr. Amar U. Kishan, University of California, Los Angeles (Abstract 217)
  • “Renal SABR in Patients with a Solitary Kidney: An Individual-Patient Pooled Analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK),” presented by Dr. Rohann Correa, London Regional Cancer Program (Abstract 222)
  • “Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiation Therapy: The NRG Oncology/RTOG 0534 SPPORT Trial,” presented by Dr. Alan Pollack, University of Miami (Abstract LBA-5)

Advances in Oral and Oligometastatic Cancers
Tuesday, October 23, 2:00 – 3:00 p.m. CT

  • “Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of A Randomized Trial,” presented by Dr. David Palma, London Health Sciences Centre (Abstract 5)
  • “NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx,” presented by Dr. Andy Trotti, Moffitt Cancer Center (Abstract LBA-4)
  • “Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-associated Oropharyngeal Cancer,” presented by Dr. Bhisham Chera, University of North Carolina (Abstract LBA-6)

ASTRO’s 60th Annual Meeting, the world’s largest scientific meeting in radiation oncology, will be held October 21-24, 2018 at the Henry B. Gonzalez Convention Center in San Antonio. The meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team. Visit ASTRO online for more information about the ASTRO Annual Meeting.

Back To Top

ASTRO announces 10 top-rated studies to be featured in news briefings at annual meeting.  Appl Rad Oncol. 

By News Release| October 01, 2018
Categories:  Section

About the Author

News Release

News Release

 



Copyright © Anderson Publishing, Ltd

 2018
    Agility CMS